TY - JOUR
T1 - Acceleration of bone regeneration of horizontal bone defect in rats using collagen-binding basic fibroblast growth factor combined with collagen scaffolds
AU - Nakamura, Shin
AU - Ito, Takashi
AU - Okamoto, Kentaro
AU - Mima, Takehiko
AU - Uchida, Kentaro
AU - Siddiqui, Yasir D.
AU - Ito, Masahiro
AU - Tai, Masako
AU - Okubo, Keisuke
AU - Yamashiro, Keisuke
AU - Omori, Kazuhiro
AU - Yamamoto, Tadashi
AU - Matsushita, Osamu
AU - Takashiba, Shogo
N1 - Funding Information:
Shogo Takashiba was supported by the Japan Agency for Medical Research and Development (AMED; Tokyo, Japan) under the Translational Research Network Program (Grant No. H27-052, H28-111), and Osamu Matsushita was supported by Japan Society for the Promotion of Science (JSPS; Tokyo, Japan) Grant-in-Aid for Scientific Research (C) (Grant No. 18K07111). We wish to thank Mr. Keisuke Tanaka at Nippi Research Institute of Biomatrix (Ibaraki, Japan) for supporting the study and providing materials, all the staff at the Department of Orthopedic surgery, Kitasato University School of Medicine (Kanagawa, Japan) for their support using micro-CT, and Dr. Nozomu Nishi at the Life Science Research Center, Kagawa University (Kagawa, Japan) for supporting the study on cell culture. Takehiko Mima, Kentaro Uchida, and Osamu Matsushita hold patents related to the methods (US9248164, EP2708246, JP5512887). All other authors report no conflicts of interest related to this study.
Publisher Copyright:
© 2019 The Authors. Journal of Periodontology published by Wiley Periodicals, Inc. on behalf of American Academy of Periodontology
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Background: Basic fibroblast growth factor (bFGF) has been applied for periodontal regeneration. However, the application depends on bone defect morphology because bFGF diffuses rapidly from defect sites. In a previous study, collagen-binding bFGF (CB-bFGF) has been shown to enhance bone formation by collagen-anchoring in the orthopedic field. The aim of this study is to demonstrate the efficacy of CB-bFGF with collagen scaffolds in bone regeneration of horizontal bone defect. Methods: Cell proliferation activity and collagen binding activity of CB-bFGF was confirmed by WST-8 assay and collagen binding assay, respectively. The retention of CB-bFGF in the collagen sheet (CS) was measured by fluorescence imaging. The rat horizontal alveolar bone defect model was employed to investigate the efficacy of CB-bFGF with collagen powder (CP). After 4 and 8 weeks, the regenerative efficacy was evaluated by microcomputed tomography, histological, and immunohistochemical analyses. Results: CB-bFGF had a comparable proliferation activity to bFGF and a collagen binding activity. CB-bFGF was retained in CS longer than bFGF. At 8 weeks postoperation, bone volume, bone mineral content, and new bone area in CB-bFGF/CP group were significantly increased compared with those in other groups. Furthermore, epithelial downgrowth was significantly suppressed in CB-bFGF/CP group. At 4 weeks, the numbers of osteocalcin, proliferating cell nuclear antigen, and osteopontin-positive cells at the regeneration site in CB-bFGF/CP group were greater than those in other groups. Conclusions: CB-bFGF/CP effectively promoted bone regeneration of horizontal bone defect possibly by sustained release of bFGF. The potential of CB-bFGF composite material for improved periodontal regeneration in vertical axis was shown.
AB - Background: Basic fibroblast growth factor (bFGF) has been applied for periodontal regeneration. However, the application depends on bone defect morphology because bFGF diffuses rapidly from defect sites. In a previous study, collagen-binding bFGF (CB-bFGF) has been shown to enhance bone formation by collagen-anchoring in the orthopedic field. The aim of this study is to demonstrate the efficacy of CB-bFGF with collagen scaffolds in bone regeneration of horizontal bone defect. Methods: Cell proliferation activity and collagen binding activity of CB-bFGF was confirmed by WST-8 assay and collagen binding assay, respectively. The retention of CB-bFGF in the collagen sheet (CS) was measured by fluorescence imaging. The rat horizontal alveolar bone defect model was employed to investigate the efficacy of CB-bFGF with collagen powder (CP). After 4 and 8 weeks, the regenerative efficacy was evaluated by microcomputed tomography, histological, and immunohistochemical analyses. Results: CB-bFGF had a comparable proliferation activity to bFGF and a collagen binding activity. CB-bFGF was retained in CS longer than bFGF. At 8 weeks postoperation, bone volume, bone mineral content, and new bone area in CB-bFGF/CP group were significantly increased compared with those in other groups. Furthermore, epithelial downgrowth was significantly suppressed in CB-bFGF/CP group. At 4 weeks, the numbers of osteocalcin, proliferating cell nuclear antigen, and osteopontin-positive cells at the regeneration site in CB-bFGF/CP group were greater than those in other groups. Conclusions: CB-bFGF/CP effectively promoted bone regeneration of horizontal bone defect possibly by sustained release of bFGF. The potential of CB-bFGF composite material for improved periodontal regeneration in vertical axis was shown.
KW - bone regeneration
KW - collagen
KW - drug delivery systems
KW - growth factors
KW - periodontitis
KW - tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=85068083606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068083606&partnerID=8YFLogxK
U2 - 10.1002/JPER.18-0674
DO - 10.1002/JPER.18-0674
M3 - Article
C2 - 30889294
AN - SCOPUS:85068083606
SN - 0022-3492
VL - 90
SP - 1043
EP - 1052
JO - Journal of Periodontology
JF - Journal of Periodontology
IS - 9
ER -